Status:

COMPLETED

Glucose in Dialysis Water in Diabetics With Chronic Renal Failure

Lead Sponsor:

Regional Hospital Holstebro

Conditions:

Renal Failure, Chronic

Diabetic Nephropathies

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purposes are 1. to measure the effect of dialysis with glucose in dialysis water on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth ...

Detailed Description

The relationship between blood pressure during dialysis treatment and vasoactive hormones are studied. This includes measurements of plasma concentration of glucose, plasma concentrations og insulin, ...

Eligibility Criteria

Inclusion

  • Age \> 18 years,
  • Both men and women,
  • Dialysis treatment for at least three month due to diabetic nephropathy

Exclusion

  • Heart failure,
  • Lung insufficiency,
  • Chronic liver disease,
  • Malignant disease,
  • Nephrotic syndrome,
  • Lack of compliance,
  • Unwillingness to participate

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00438503

Start Date

May 1 2006

End Date

May 1 2007

Last Update

September 15 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Holstebro Hospital

Holstebro, Denmark, 7500